Company intelligence / Profile preview
Nexus Alliance Biopharma
Orlando, Florida, USAnexusalliancebiopharma.com ↗
- Ownership
- Private
- Development stage
- Phase 3
01
Overview
NAB is preparing for launching and approval of multiple products via 505(B2) route and conducting Phase III clinical trials. They have published positive Phase II clinical trial results.
- Therapeutic areas
- Infectious Diseases
- Modalities
- Conjugate delivery particlesinjectable drugsdiagnostic tests
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Works with "top therapeutically decisive centres of excellence"
Beyond the preview
Go deeper on Nexus Alliance Biopharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nexus Alliance Biopharma.